ciglitazone has been researched along with Anaplastic Astrocytoma in 2 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Ortiz, JM | 1 |
| Tranque, P | 1 |
| Burgos, M | 1 |
| Vaquero, CF | 1 |
| Llopis, J | 1 |
| Galetto, R | 1 |
| Albajar, M | 1 |
| Polanco, JI | 1 |
| Zakin, MM | 1 |
| Rodríguez-Rey, JC | 1 |
2 other studies available for ciglitazone and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxide.
Topics: Animals; Astrocytoma; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Line, Tumor; Electron | 2007 |
Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region.
Topics: Animals; Apolipoproteins E; Astrocytoma; Base Sequence; Binding Sites; CCAAT-Enhancer-Binding Protei | 2001 |